All News #Library
Others
Odyssey Therapeutics Taps Jolie Siegel as EVP, General Counsel
21 Jan 2026 //
BUSINESSWIRE
Odyssey Therapeutics Appoints Pharma Leader Nia Tatsis to Board
09 Oct 2025 //
PHARMIWEB
Odyssey Rebounds Off Failed IPO With $213M Series D
10 Sep 2025 //
BIOSPACE
Odyssey Therapeutics Appoints Jason as Chief Financial Officer
08 Jan 2025 //
BUSINESSWIRE
Odyssey and Terray Therapeutics Collaborate on 1st-in-Class Therapy
28 Oct 2024 //
BUSINESSWIRE
Odyssey Therapeutics Shares Data on RIPK2 Inhibitor at ACG
27 Oct 2024 //
BUSINESSWIRE
Odyssey Announces Collab to Advance AI-Driven Small Molecule Drug Discovery
04 Apr 2024 //
BUSINESSWIRE
Odyssey Appoints Julie Clauss as COO and Butler as SVP, Head of Chemistry
02 Apr 2024 //
BUSINESSWIRE
Odyssey raises epic $101M to push programs off to clinical sea
05 Dec 2023 //
FIERCE BIOTECH
Odyssey Therapeutics to Present Data for Three Immunology Programs
09 Nov 2023 //
BUSINESSWIRE
Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer
04 Oct 2023 //
BUSINESSWIRE
Odyssey Expands Management Team with Key Appointments in R&D and Strategy
09 Nov 2022 //
PRNEWSWIRE

Market Place
Sourcing Support